Clinical interface security: a dated CISA remediation baseline

Non-photo editorial diagram showing evidence, review and decisions — Primary evidence passes through two native agents and exact-field validation. AI-generated, non-photo editorial diagram · MedCareIT

This edition reviews 1 selected entry in CISA primary catalog, catalog version 2026.11.04, released 2026-11-04. The catalog contains 1768 entries across all sectors globally. This selection is not a complete count of healthcare vulnerabilities and is not a USA-only total.

A listing establishes that CISA includes the named vulnerability in its Known Exploited Vulnerabilities catalog. It does not establish a new incident, current exploitation at a particular hospital, affected local versions, or a breach of patient records. Historical addition dates remain explicit below.

Health IT Developments

Story	Key Details	What This Means for Hospitals	Status
CVE-2023-43208 · Mirth Connect	CISA added 2024-05-20; catalog as of 2026-11-04. CISA primary catalog.	Verify inventory and vendor version applicability; follow supported mitigation guidance.	Verified · existing catalog listing

EHR & Interoperability

The selected product names are Mirth Connect. Review potential relevance to the clinical systems inventory. The source does not identify which hospitals operate an affected version.

Clinical AI

No source-verified clinical AI development is promoted in this run. This is a coverage limitation, not evidence that no developments occurred. No vendor accuracy or outcome claim is published.

Five Things That Changed

These are five dated checks from this run, not five assertions of new events today.

Primary-source catalog version: 2026.11.04.
Catalog release date: 2026-11-04.
Entries across all sectors globally: 1768.
Selected entries in this edition: 1; original addition dates: CVE-2023-43208: 2024-05-20.
Historical CISA due dates: CVE-2023-43208: 2024-06-10. These dates are not represented as universal hospital compliance deadlines.

Data Ledger

Publication date: 2026-11-05 (America/Chicago).
Evidence as of: 2026-11-04; CISA primary catalog.
Region: Global catalog evidence; no inferred regional patient or breach counts.
Selection: explicit clinical-product name patterns, limited to 25 entries per edition. Unselected items are not classified as safe.

Breach Radar

No source-verified hospital incident is promoted from this catalog review. A vulnerability listing is not a breach report. Monthly breach counts are unavailable in this workflow; no zero-breach claim is made. Sample breach rows remain individually labelled.

Vendors & Deals

Vendor names are reproduced only as product identifiers in the primary-source catalog. No deal, investment conclusion, product endorsement, vendor accuracy percentage or outcome claim is introduced.

Policy & Standards

The source records these CISA due dates: CVE-2023-43208: 2024-06-10. The edition does not extend those dates to all hospitals or assert a new regional legal obligation. Consult the applicable regulator and vendor guidance.

Forecast Updates

No new forecast is introduced by this run. Existing forecast records, including contradicted and expired examples, remain in the public ledger with their SAMPLE labels.

Source Notes

CISA primary catalog: version 2026.11.04, released 2026-11-04; fetched independently for this run.
Native OpenClaw selects only IDs present in the supplied primary-source evidence.
Native Hermes reviews the selection. Every published source field must exactly match the independently fetched snapshot; any mismatch stops publication.
No anonymous reporting, patient-level data, exploit vectors or payloads are included. Mitigations reproduce the catalog’s required action.
AI review is automated. Human review remains necessary for disputed evidence, regional extrapolation and any interpretation outside this source-constrained workflow.